Robert Law, Ph.D.
Senior Immunoassay Scientist @ AOA Dx
About Robert Law, Ph.D.
Robert Law, Ph.D., is a Senior Immunoassay Scientist specializing in cancer diagnostics and prevention, currently focusing on ovarian cancer diagnostic tests and expanding cancer detection technologies.
Known information
Robert Law, Ph.D., serves as a Senior Immunoassay Scientist, with a distinguished educational background including a Ph.D. in Chemical and Biomolecular Engineering from Johns Hopkins University and a B.S. from The Ohio State University in the same field, where he graduated ‘With Research Distinction’. His professional journey is marked by significant contributions to the field of cancer diagnostics, particularly through his work on AOA’s ovarian cancer diagnostic test and the enhancement of the GlycoLocate™ platform, which aims to identify additional cancer targets. Dr. Law’s research has been widely recognized, resulting in several publications in prestigious journals such as Science Advances, Science Signaling, Journal of Cell Biology, and Cancer Research. His commitment to addressing complex issues in cancer diagnostics and prevention underscores his role as a leader in the scientific community.
About AOA Dx
AOA Dx, headquartered in New York, NY, and Cambridge, MA, is a healthcare company specializing in early cancer detection technologies, particularly focusing on ovarian cancer through innovative blood tests like GlycoLocate™ and AKRIVIS GD™.